Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...
A slew of new studies and reports suggest that new molecular approaches may soon help reduce the global burden of tuberculosis.
Evo’s success wasn’t limited to proteins. When they tested a different toxin that had an RNA-based inhibitor, the system ...
Background and aims The centenary of Archives of Disease in Childhood ( ADC ) presents an opportunity to reflect on a century ...
Background Eosinophilic oesophagitis (EoE) is a chronic allergic disease characterised by oesophageal epithelial remodelling, barrier dysfunction and inflammation. The transcription factor forkhead ...
The newly described microbe represents a world of parasitic, intercellular biodiversity only beginning to be revealed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results